MicroRNAs in platelet function and cardiovascular disease

Nature Reviews Cardiology

Volumn 12, Issue 12, 2015, Pages 711-717

  McManus, David D ^a   Freedman, Jane E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; SMALL UNTRANSLATED RNA; UNTRANSLATED RNA;

ATRIAL FIBRILLATION; CELL TRANSFER; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; HEART INFARCTION; HUMAN; MEGAKARYOPOIESIS; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PLATELET MICROPARTICLE; PLATELET REACTIVITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN HOMEOSTASIS; REVIEW; RNA SEQUENCE; RNA TRANSPORT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; VASOCONSTRICTION; CARDIOVASCULAR DISEASE; GENE EXPRESSION REGULATION; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOCYTE;

BLOOD PLATELETS; CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS;

EID: 84947867149     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2015.101     Document Type: Review

References (84)

1. Roger, V. L. et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123, e18-e209 (2011).
2. Roger, V. L. et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125, e2-e220 (2012).
3. Writing Group Members. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121, e46-e215 (2010).
4. Michelson, A. D. Platelets 3rd edn (Academic Press, 2012).
5. Lackie, J. A Dictionary of Biomedicine (Oxford University Press, 2010).
6. Davies, M. J. & Thomas, A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N. Engl. J. Med. 310, 1137-1140 (1984).
7. Falk, E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br. Heart J. 50, 127-134 (1983).
8. Sherman, C. T. et al. Coronary angioscopy in patients with unstable angina pectoris. N. Engl. J. Med. 315, 913-919 (1986).
9. Zimmerman, G. A. & Weyrich, A. S. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler. Thromb. Vasc. Biol. 28, s17-s24 (2008).
10. Weyrich, A. S., Schwertz, H., Kraiss, L. W. & Zimmerman, G. A. Protein synthesis by platelets: historical and new perspectives. J. Thromb. Haemost. 7, 241-246 (2009).
11. Rowley, J. W. et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 118, e101-e111 (2011).
12. Rowley, J. W., Schwertz, H. & Weyrich, A. S. Platelet mRNA: the meaning behind the message. Curr. Opin. Hematol. 19, 385-391 (2012).
13. Bugert, P., Dugrillon, A., Günaydin, A., Eichler, H. & Klüter, H. Messenger RNA profiling of human platelets by microarray hybridization. Thromb. Haemost. 90, 738-748 (2003).
14. Gnatenko, D. V. et al. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 101, 2285-2293 (2003).
15. Bray, P. F. et al. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics 14, 1 (2013).
16. McRedmond, J. P. et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol. Cell. Proteomics 3, 133-144 (2004).
17. Londin, E. R. et al. The human platelet: strong transcriptome correlations among individuals associate weakly with the platelet proteome. Biol. Direct 9, 3 (2014).
18. Renaud, B., Buda, M., Lewis, B. D. & Pujol, J. F. Effects of 5,6-dihydroxytryptamine on tyrosine-hydroxylase activity in central catecholaminergic neurons of the rat. Biochem. Pharmacol. 24, 1739-1742 (1975).
19. Nagalla, S. et al. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 117, 5189-5197 (2011).
20. Ambros, V., Lee, R. C., Lavanway, A., Williams, P. T. & Jewell, D. MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr. Biol. 13, 807-818 (2003).
21. Carrington, J. C. & Ambros, V. Role of microRNAs in plant and animal development. Science 301, 336-338 (2003).
22. Ambros, V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113, 673-676 (2003).
23. Ambros, V. MicroRNAs: tiny regulators with great potential. Cell 107, 823-826 (2001).
24. Ambros, V. MicroRNAs and developmental timing. Curr. Opin. Genet. Dev. 21, 511-517 (2011).
25. Cloonan, N. Re-thinking miRNA-mRNA interactions: intertwining issues confound target discovery. Bioessays 37, 379-388 (2015).
26. Small, E. M. & Olson, E. N. Pervasive roles of microRNAs in cardiovascular biology. Nature 469, 336-342 (2011).
27. Wahlgren, J. et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res. 40, e130 (2012).
28. Heijnen, H. F., Schiel, A. E., Fijnheer, R., Geuze, H. J. & Sixma, J. J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94, 3791-3799 (1999).
29. Small, E. M., Frost, R. J. A. & Olson, E. N. MicroRNAs add a new dimension to cardiovascular disease. Circulation 121, 1022-1032 (2010).
30. van Rooij, E. et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579 (2007).
31. Hinkel, R., Ng, J. K. M. & Kupatt, C. Targeting microRNAs for cardiovascular therapeutics in coronary artery disease. Curr. Opin. Cardiol. 29, 586-594 (2014).
32. Dong, S. et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J. Biol. Chem. 284, 29514-29525 (2009).
33. Wang, R., Li, N., Zhang, Y., Ran, Y. & Pu, J. Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Intern. Med. 50, 1789-1795 (2011).
34. McManus, D. D. & Ambros, V. Circulating MicroRNAs in cardiovascular disease. Circulation 124, 1908-1910 (2011).
35. McManus, D. D. et al. Relations between circulating microRNAs and atrial fibrillation: data from the Framingham Offspring Study. Heart Rhythm 11, 663-669 (2014).
36. McManus, D. D. et al. Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study). Heart Rhythm 12, 3-10 (2015).
37. Fichtlscherer, S. et al. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107, 677-684 (2010).
38. Freedman, J. E. et al. The distribution of circulating microRNA and their relation to coronary disease. F1000Res. 1, 50 (2012).
39. De Rosa, S. et al. Transcoronary concentration gradients of circulating microRNAs. Circulation 124, 1936-1944 (2011).
40. Fichtlscherer, S., Zeiher, A. M. & Dimmeler, S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases Arterioscler. Thromb. Vasc. Biol. 31, 2383-2390 (2011).
41. Oliveira-Carvalho, V., da Silva, M. M. F., Guimarães, G. V., Bacal, F. & Bocchi, E. A. MicroRNAs: new players in heart failure. Mol. Biol. Rep. 40, 2663-2670 (2013).
42. Liebetrau, C. et al. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. J. Am. Coll. Cardiol. 62, 992-998 (2013).
43. Das, S. & Halushka, M. K. Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc. Pathol. 24, 199-206 (2015).
44. Bang, C. et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J. Clin. Invest. 124, 2136-2146 (2014).
45. Georgantas, R. W. et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl Acad. Sci. USA 104, 2750-2755 (2007).
46. Barroga, C. F., Pham, H. & Kaushansky, K. Thrombopoietin regulates c-Myb expression by modulating micro RNA 150 expression. Exp. Hematol. 36, 1585-1592 (2008).
47. Opalinska, J. B. et al. MicroRNA expression in maturing murine megakaryocytes. Blood 116, e128-e138 (2010).
48. Labbaye, C. et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat. Cell Biol. 10, 788-801 (2008).
49. Stratz, C. et al. Micro-array profiling exhibits remarkable intra-individual stability of human platelet micro-RNA. Thromb. Haemost. 107, 634-641 (2012).
50. Xu, X. et al. Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms. Blood 120, 3575-3585 (2012).
51. Plé, H. et al. The repertoire and features of human platelet microRNAs. PLoS ONE 7, e50746 (2012).
52. Cecchetti, L. et al. Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. Blood 118, 1903-1911 (2011).
53. Diehl, P. et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc. Res. 93, 633-644 (2012).
54. Freedman, J. E. et al. Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation 122, 119-129 (2010).
55. Lood, C. et al. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood 116, 1951-1957 (2010).
56. Simon, L. M. et al. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood 123, e37-e45 (2014).
57. Jain, S. et al. Expression of regulatory platelet microRNAs in patients with sickle cell disease. PLoS ONE 8, e60932 (2013).
58. Healy, A. M. et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 113, 2278-2284 (2006).
59. Gidlöf, O. et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood 121, 3908-3917 (2013).
60. Kahr, W. H. A. et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat. Genet. 43, 738-740 (2011).
61. Gnatenko, D. V. et al. Class prediction models of thrombocytosis using genetic biomarkers. Blood 115, 7-14 (2010).
62. Landry, P. et al. Existence of a microRNA pathway in anucleate platelets. Nat. Struct. Mol. Biol. 16, 961-966 (2009).
63. Willeit, P. et al. Circulating microRNAs as novel biomarkers for platelet activation. Circ. Res. 112, 595-600 (2013).
64. Kondkar, A. A. et al. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J. Thromb. Haemost. 8, 369-378 (2010).
65. Gatsiou, A., Boeckel, J.-N., Randriamboavonjy, V. & Stellos, K. MicroRNAs in platelet biogenesis and function: implications in vascular homeostasis and inflammation. Curr. Vasc. Pharmacol. 10, 524-531 (2012).
66. Risitano, A., Beaulieu, L. M., Vitseva, O. & Freedman, J. E. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood 119, 6288-6295 (2012).
67. Aatonen, M., Grönholm, M. & Siljander, P. R.-M. Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin. Thromb. Hemost. 38, 102-113 (2012).
68. Montecalvo, A. et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119, 756-766 (2012).
69. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007).
70. Laffont, B. et al. Activated platelets can deliver mRNA regulatory Ago2-microRNA complexes to endothelial cells via microparticles. Blood 122, 253-261 (2013).
71. Pan, Y. et al. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J. Immunol. 192, 437-446 (2014).
72. Ward, J. A. et al. Circulating cell and plasma microRNA profiles differ between non-ST-segment and ST-segment-elevation myocardial infarction. Fam. Med. Med. Sci. Res. 2, 108 (2013).
73. de Boer, H. C. et al. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur. Heart J. 34, 3451-3457 (2013).
74. Hunter, M. P. et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3, e3694 (2008).
75. Italiano, J. E., Mairuhu, A. T. A. & Flaumenhaft, R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr. Opin. Hematol. 17, 578-584 (2010).
76. Cheng, H. H. et al. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS ONE 8, e64795 (2013).
77. Zampetaki, A. et al. Prospective study on circulating microRNAs and risk of myocardial infarction. J. Am. Coll. Cardiol. 60, 290-299 (2012).
78. Goren, Y. et al. Relation of reduced expression of miR-150 in platelets to atrial fibrillation in patients with chronic systolic heart failure. Am. J. Cardiol. 113, 976-981 (2014).
79. Tang, Y. et al. MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death. Cardiovasc. Res. 106, 387-397 (2015).
80. Hulsmans, M. & Holvoet, P. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc. Res. 100, 7-18 (2013).
81. Zhang, Y.-Y. et al. Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. J. Thromb. Thrombolysis 38, 65-72 (2014).
82. Duisters, R. F. et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ. Res. 104, 170-178 (2009).
83. Karolina, D. S. et al. Circulating miRNA profiles in patients with metabolic syndrome. J. Clin. Endocrinol. Metab. 97, E2271-E2276 (2012).
84. Wang, Y.-S., Zhou, J., Hong, K., Cheng, X.-S. & Li, Y.-G. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase. Cell. Physiol. Biochem. 35, 1546-1556 (2015).